REGULATED PRESS RELEASE published on 09/05/2024 at 07:30, 1 year 3 months ago Gimv verkoopt belang in Mega International aan Bizzdesign dat zo een sterke leiderspositie verwerft in Enterprise Architecture en Digital Transformation Gimv verkoopt belang in Mega International aan Bizzdesign, resulterend in sterke leiderspositie in Enterprise Architecture en Digital Transformation. Overname gerealiseerd met Main Capital als investeerder Digital Transformation Gimv Mega International Bizzdesign Enterprise Architecture
REGULATED PRESS RELEASE published on 09/05/2024 at 07:30, 1 year 3 months ago Gimv cède sa participation dans Mega International à Bizzdesign, ce nouvel ensemble formant un leader dans le domaine de l'architecture d'entreprise et de la transformation numérique Gimv cède sa participation dans Mega International à Bizzdesign, créant ainsi un leader dans l'architecture d'entreprise et la transformation numérique. Main Capital soutient cette fusion. Consultez le communiqué de presse pour plus d'informations Gimv Mega International Bizzdesign Architecture D'entreprise Main Capital
REGULATED PRESS RELEASE published on 09/05/2024 at 07:30, 1 year 3 months ago Gimv sells stake in Mega International to Bizzdesign, establishing a strong leadership position in the Enterprise Architecture and Digital Transformation space Gimv sells stake in Mega International to Bizzdesign, establishing a strong leadership position in Enterprise Architecture & Digital Transformation. The financial impact of the transaction was previously disclosed. Closing is pending regulatory approvals. Luca de Risi, CEO of Mega International, highlights the strategic match with Bizzdesign Digital Transformation Gimv Mega International Bizzdesign Enterprise Architecture
PRESS RELEASE published on 09/05/2024 at 07:30, 1 year 3 months ago Informations privilégiées / Autres communiqués Teva, partenaire de Medincell, annonce des avancées importantes dans l'essai clinique pivot de phase 3 de l'Olanzapine injectable à durée d’action prolongée, avec un taux élevé d'injections réalisées et des résultats positifs attendus Schizophrénie Essai Clinique Medincell Olanzapine Teva
PRESS RELEASE published on 09/05/2024 at 07:30, 1 year 3 months ago Inside Information / Other news releases Teva provides update on pivotal Phase 3 of Olanzapine LAI by Medincell. Safety results on track for H2 2024. Potential innovative long-acting antipsychotic treatment Clinical Trials Phase 3 Medincell Teva Olanzapine LAI
PRESS RELEASE published on 09/05/2024 at 07:30, 1 year 3 months ago 2024 HALF-YEAR RESULTS Voltalia reports its consolidated half-year results for 2024, showing EBITDA up by 34% to 75 million euros driven by increased turnover. Outlook for 2024 impacted by Brazilian grid operator curtailment and exchange rate EBITDA Brazil 2024 Turnover Voltalia
PRESS RELEASE published on 09/05/2024 at 07:28, 1 year 3 months ago P&P Group Celebrates Another Sales Milestone: Over 200 Residential Units Sold at Lagarde Campus in Bamberg P&P Group celebrates surpassing 200 residential unit sales at Lagarde Campus in Bamberg, showcasing prime location, quality, and design amidst a demanding market environment Real Estate P&P Group Sales Milestone Residential Units Lagarde Campus
REGULATED PRESS RELEASE published on 09/05/2024 at 07:01, 1 year 3 months ago bioMérieux – First-Half 2024 Results
PRESS RELEASE published on 09/05/2024 at 07:00, 1 year 3 months ago Un premier semestre 2024 très réjouissant pour Espace Espace Real Estate AG annonce des résultats semestriels très positifs pour le premier semestre 2024, avec une augmentation des recettes de location et du bénéfice, ainsi qu'un faible taux de vacance Espace Real Estate AG Résultat Semestriel Augmentation Recettes Bénéfice En Hausse Taux De Vacance Faible
Published on 01/02/2026 at 19:50, 11 minutes ago Datavault AI and The Dream Bowl to Set New Benchmark in Sports Innovation with World’s First Tokenized Autograph Session, Featuring Current and Future NFL Stars - Live on ESPN+
Published on 01/02/2026 at 15:00, 5 hours 1 minute ago Jaguar Health Awarded $240,000 FDA Grant in Support of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Published on 01/02/2026 at 14:00, 6 hours 1 minute ago Metallic Minerals Provides Corporate Update and Responds to Recent Market Activity
Published on 01/02/2026 at 13:10, 6 hours 51 minutes ago Organto Foods Inc. Announces Proposed Early Warrant Exercise Incentive
Published on 01/02/2026 at 13:00, 7 hours 1 minute ago Golden Minerals Company Substantially Reduces Liabilities in Mexico
Published on 01/02/2026 at 18:55, 1 hour 6 minutes ago Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares
Published on 01/02/2026 at 18:43, 1 hour 18 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 01/02/2026 at 18:25, 1 hour 35 minutes ago Bitmine Publishes New Chairman's Message Explaining Why Shareholders Should Vote YES to Approve the Amendment to Increase Authorized Shares
Published on 01/02/2026 at 17:15, 2 hours 46 minutes ago Hong Kong Tech Exhibits Immense Potential at CES 2026 with 61 Tech Companies Ready for Global Markets
Published on 01/02/2026 at 17:45, 2 hours 16 minutes ago Mise en ligne du document « Pre-FY 2025 Results Communication »
Published on 01/02/2026 at 17:45, 2 hours 16 minutes ago Availability of the Pre-FY 2025 Results Communication
Published on 12/29/2025 at 19:14, 4 days ago Infotel : Déclaration des transactions sur actions propres réalisées du 22 au 26 décembre 2025 dans le cadre du programme de rachat d’actions.
Published on 12/29/2025 at 18:05, 4 days 1 hour ago Covivio - Déclaration des transactions sur actions propres réalisées du 22 décembre au 24 décembre 2025
Published on 12/29/2025 at 18:05, 4 days 1 hour ago Covivio - Treasury shares transactions between December 22nd , 2025 and December 24th, 2025